Get the Stockscreener App
270.49
0.04%
0.11
Pre-market:
270.48
-0.010
-0.00%
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $270.49, with a volume of 586.95K.
It is up +0.04% in the last 24 hours and up +10.98% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$270.38
Open:
$271.06
24h Volume:
586.95K
Relative Volume:
0.84
Market Cap:
$22.48B
Revenue:
$13.48B
Net Income/Loss:
$764.50M
P/E Ratio:
29.86
EPS:
9.06
Net Cash Flow:
$1.26B
1W Performance:
+1.05%
1M Performance:
+10.98%
6M Performance:
+9.83%
1Y Performance:
+18.90%
1-Day Range:
$269.68
$271.68
1-Week Range:
$267.17
$272.66
52-Week Range:
$209.38
$283.47
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
270.49 | 22.47B | 13.48B | 764.50M | 1.26B | 9.06 |
|
TMO
Thermo Fisher Scientific Inc
|
487.54 | 184.66B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
209.01 | 151.04B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
637.86 | 52.07B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
118.15 | 33.86B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
192.54 | 32.49B | 15.70B | 1.24B | 2.01B | 6.91 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72 - simplywall.st
Published on: 2025-08-19 00:48:14 - beatles.ru
LabCorp Prevails in ERISA Trial, While Case Against NextEra Allowed to Proceed - plansponsor
Labcorp launches first FDA-cleared blood test for Alzheimer's disease - MarketScreener
Labcorp launches first FDA-cleared blood test for Alzheimer’s disease By Investing.com - Investing.com South Africa
Labcorp Holdings Launches FDA-Cleared Blood Test Lumipulse to Help Diagnose Alzheimer's Disease - MarketScreener
Labcorp Announces Availability Of Lumipulse PTau-217/Beta Amyloid 42 Ratio For Alzheimer's Diagnosis - Nasdaq
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease - MarketScreener
Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation - MSN
Insider Transactions at Labcorp Holdings: A Balancing Act of Confidence and Caution - AInvest
What makes Labcorp Holdings Inc. stock price move sharply2025 Earnings Impact & Fast Entry High Yield Tips - sundaytimes.kr
Labcorp Executive Makes a Million-Dollar Move! - TipRanks
Labcorp Holdings shares rise 1.66% after-hours following insider share sales. - AInvest
After 3 years, federal judge dismisses 401(k) lawsuit against LabCorp - Pensions & Investments
Labcorp EVP van der Vaart sells $1.06m in shares By Investing.com - Investing.com Australia
LabCorp Fails to Block Natera Patent-Invalidity Claims Pre-Trial - Bloomberg Law News
Labcorp EVP van der Vaart sells $1.06m in shares - Investing.com
Labcorp Holdings Insider Sells Shares Worth $1.06mln in Recent SEC Filing - AInvest
Labcorp Holdings Insider Sold Shares Worth $1,059,371, According to a Recent SEC Filing - MarketScreener
Here's Why Labcorp Holdings (LH) is a Strong Value Stock - Yahoo Finance
Stock Analysis | Labcorp OutlookMixed Signals Amid Analyst Optimism and Weak Technicals - AInvest
Labcorp’s SWOT analysis: diagnostic giant faces PAMA headwinds, stock outlook mixed - Investing.com
Drug Discovery Services Company Evaluation Report 2025 | LabCorp, Evotec, and Selvita Lead with Comprehensive Research and Laboratory Services - Yahoo Finance
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire Inc.
Machine Learning Models Forecast Labcorp Holdings Inc. Uptick2025 Volatility Report & Fast Gain Swing Alerts - mustnews.co.kr
Quant Funds Rotate Into Labcorp Holdings Inc. StockJuly 2025 Selloffs & Consistent Income Trade Recommendations - sisa-n.com
Labcorp Wins ERISA Trial As Judge Cites Stronger Witnesses - Law360
Labcorp Holdings Short Interest Falls, Signaling Bullish Market Sentiment - AInvest
Labcorp CEO Schechter sells $1.5m in shares By Investing.com - Investing.com Canada
Labcorp CEO Schechter sells $1.5m in shares - Investing.com
LabCorp Scores Trial Victory in 401(k) Plan Fee Class Challenge - news.bloombergtax.com
Labcorp Holdings Sees RS Rating Rise To 73 - Investor's Business Daily
Labcorp Holdings: How Non-GAAP Adjustments Reveal a Stronger Earnings Story and a Potentially Undervalued Stock - AInvest
Investing in Labcorp Holdings (NYSE:LH) Five Years Ago Would Have Delivered You a 71% Gain - 富途牛牛
Analysts Have Conflicting Sentiments on These Healthcare Companies: Labcorp Holdings (LH), Bausch + Lomb Corporation (BLCO) and Radnet (RDNT) - The Globe and Mail
What analysts say about Labcorp Holdings Inc. stock outlookAlpha Focused Technical Trade Signals Gain Attention - beatles.ru
Is Labcorp Holdings Inc. a growth stock or a value stockDynamic portfolio growth - Jammu Links News
Is it the right time to buy Labcorp Holdings Inc. stockBuild your wealth with consistent stock growth - Jammu Links News
How strong is Labcorp Holdings Inc. company’s balance sheetHigh-yield growth strategies - Jammu Links News
How many analysts rate Labcorp Holdings Inc. as a “Buy”Free Investment Risk Control - Jammu Links News
Does Labcorp Holdings Inc. stock perform well during market downturnsCapitalize on high-yield stock opportunities - Jammu Links News
When is Labcorp Holdings Inc. stock expected to show significant growthHigh-margin investment plays - Jammu Links News
What is the dividend policy of Labcorp Holdings Inc. stockCapitalize on market trends early - Jammu Links News
What are Labcorp Holdings Inc. company’s key revenue driversFree Consultation - Jammu Links News
Gilliland, Labcorp director, sells $529k in stock - Investing.com
Gilliland, Labcorp director, sells $529k in stock By Investing.com - Investing.com Canada
Can a trend reversal in Labcorp Holdings Inc. lead to recoveryMomentum Based Equity Trading Plans Reviewed - metal.it
Labcorp Holdings (LH) Unveils Test Finder: AI Tool for Streamlined Lab Test Selection - Yahoo Finance
Labcorp Holdings: Top Momentum Stock for Long-Term Investors - AInvest
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Advanced analytics toolkit walkthrough for Labcorp Holdings Inc.Buy Low Sell High Stock Watch Strategy in Focus - metal.it
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):